Document 0261 DOCN M94A0261 TI Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. DT 9412 AU Lin HJ; Myers LE; Yen-Lieberman B; Hollinger FB; Henrard D; Hooper CJ; Kokka R; Kwok S; Rasheed S; Vahey M; et al; Division of Molecular Virology, Baylor College of Medicine,; Houston, Texas. SO J Infect Dis. 1994 Sep;170(3):553-62. Unique Identifier : AIDSLINE MED/94358487 AB Six procedures for quantifying plasma human immunodeficiency virus type 1 (HIV-1) RNA were evaluated by nine laboratories. The procedures differed in their sample volume and preparation of samples and methods of amplification and detection. Coded samples in a 10-fold dilution series of HIV-1-spiked plasma were correctly ranked by all six procedures. Subsequently, coded duplicate plasma samples from 16 HIV-1-infected patients were tested using a common set of standards. Several HIV-1 RNA procedures were sufficiently reproducible so that an empiric 4-fold change could be viewed as significant. HIV-1 RNA levels in the patients (up to 370,000 RNA copies/mL) correlated with proviral HIV-1 DNA and were inversely correlated with CD4 cell counts; HIV-1 RNA assays were more sensitive than plasma viremia, standard p24 antigen, or immune complex-dissociated p24 antigen assays. This study demonstrated that several HIV-1 RNA quantitative assays are ready for use in clinical trials. DE Acquired Immunodeficiency Syndrome/BLOOD/*DIAGNOSIS Blood Specimen Collection Comparative Study Human HIV Core Protein p24/BLOOD *HIV Seronegativity HIV Seropositivity/BLOOD/*DIAGNOSIS HIV-1/*ISOLATION & PURIF Laboratories/STANDARDS Leukocyte Count Predictive Value of Tests RNA, Viral/*BLOOD Sensitivity and Specificity Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. T4 Lymphocytes Viremia/BLOOD JOURNAL ARTICLE MULTICENTER STUDY SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).